[4] Galindo, R.J., Cheng, A.Y.Y., Longuet, C
Bar chart showing percentage of participants achieving weight reduction targets of 10% to 30% with tirzepatide versus semaglutide in the SURMOUNT-5 trial How Tirzepatide Differs from Other Weight Loss Injections Several GLP-1 receptor agonist medications are available for weight management in Singapore, including Ozempic (semaglutide) and Saxenda (liraglutide)
FAERS data and meta-analyses A disproportionality analysis of the FDAs FAERS reporting database (Godfrey et al., JEADV 2025) found a reporting odds ratio of 1.73 for tirzepatide (95% confidence interval 1.42 to 2.09), and 2.46 for semaglutide
Her nurse practitioner happened to have a sample box of the medication on hand, so Robinson walked out with a free month's supply of the medication, and no idea how much it cost
Tirzepatides dual-action approach targets both GLP-1 and GIP receptors, allowing it to address multiple metabolic pathways for improved results